New Industry Standards for Bioequivalence Testing on 43 Ingredients

The Korea Food and Drug Administration (KFDA) recently released the standard bioequivalence testing guidance on 43 pharmaceutical active ingredients, including gabapentin, glimepiride, rebamipide, and cefroxidine, among others.

With these additions, there are currently 139 active ingredients in total with their standard bioequivalence testing guidance established by the KFDA, where 52 ingre...